Stock Award Plans and Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Grant Date Fair Value

There were 1,700   stock options granted during the three months ended March 31, 2022.  The assumptions underlying the calculation of grant date fair value per share for the three months ended March 31, 2022 are as follows:

	For the Three Months Ended March 31,
	2022
Number of options granted		1,700
Weighted-average expected volatility		117.18	%
Weighted-average risk-free interest rate		1.68	%
Weighted-average expected option term    (in years)		6.25
Weighted-average dividend yield		—	%
Weighted-average fair value per share    of grants	$	6.92

Schedule of Stock-based Compensation Expense

The Company recognized stock-based compensation expense related to the issuance of stock option awards, restricted stock awards and restricted stock units to employees, non-employees and directors in the statements of operations as follows:

	Three Months Ended
	March 31,
	2022		2021
Cost of goods sold	$	14,755	$	9,033
Research and development		29,612		47,403
Selling, general and administrative		221,903		109,535
Total	$	266,270	$	165,971